|
Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA) -Pub
|
|
0
|
136
|
October 29, 2024
|
|
N-Nitrosamine drug substance related impurities (NDSRIs) – A proposal for the addition of subcategories to carcinogenic potency categorization approach categories 1 and 2 for NDSRIs with a molecular weight > 200 Da -Pub
|
|
0
|
183
|
October 28, 2024
|
|
🖩 CPCA Calculation Tool (excel-based) -Updated
|
|
87
|
10705
|
September 27, 2024
|
|
Using the Carcinogenicity Potency Categorization Algorithm to Predict N-Nitrosamine Carcinogenicity -Webinar
|
|
0
|
352
|
May 13, 2024
|
|
Calculation of Nitrosamines AI not covered by CPCA
|
|
3
|
990
|
December 20, 2023
|